Abzena PLC (LON:ABZA)‘s stock had its “corporate” rating restated by investment analysts at N+1 Singer in a report released on Thursday.

Separately, FinnCap restated a “buy” rating on shares of Abzena PLC in a research report on Friday, November 18th.

Abzena PLC (LON:ABZA) opened at 32.40 on Thursday. The firm has a 50-day moving average price of GBX 37.74 and a 200 day moving average price of GBX 42.01. The firm’s market cap is GBX 44.12 million. Abzena PLC has a 1-year low of GBX 31.00 and a 1-year high of GBX 65.00.

TRADEMARK VIOLATION WARNING: “Abzena PLC (ABZA) Receives “Corporate” Rating from N+1 Singer” was published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2016/11/24/abzena-plc-abza-receives-corporate-rating-from-n1-singer.html.

Abzena PLC Company Profile

Abzena plc is a life sciences company providing services and technologies. The Company is engaged in the provision of services and technology licenses. The Company consists of PolyTherics and Antitope, which have established a suite of services and technologies that are designed to improve the chances of development of antibodies and proteins with therapeutic benefits.

Receive News & Stock Ratings for Abzena PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena PLC and related stocks with our FREE daily email newsletter.